Related Experiment Videos

Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy

J Kato1, H Wanebo, P Calabresi

  • 1Department of Medicine, Roger Williams Medical Center, Providence, RI.

Melanoma Research
|May 1, 1992
PubMed

Insights

Human melanoma cells proliferate in response to growth factors. Insulin-like growth factor-I (IGF-I) and basic fibroblast growth factor (bFGF) showed significant effects, suggesting potential therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Human malignant melanoma cell lines exhibit variable responses to exogenous growth factors.
  • Growth factors play a crucial role in stimulating cell proliferation.

Purpose of the Study:

  • To investigate the effects of various exogenous growth factors on human metastatic melanoma cell lines.
  • To determine the role of basic fibroblast growth factor (bFGF) and its receptors in melanoma cell proliferation.

Main Methods:

  • Tested mitogenic activity of nine growth factors using [3H]thymidine incorporation assay.
  • Quantified bFGF production and [125I]bFGF binding.
  • Utilized antisense oligodeoxynucleotides to inhibit bFGF coding region.

Main Results:

  • All tested melanoma cell lines responded to insulin-like growth factor-I (IGF-I).
  • Combinations of bFGF and IGF-I demonstrated additive effects, significantly enhancing proliferation in some cell lines.
  • Melanoma cell lines produced bFGF and expressed high-affinity bFGF receptors.
  • Antisense inhibition of bFGF reduced proliferation, indicating partial autocrine control.

Conclusions:

  • Melanoma cell proliferation is influenced by multiple growth factors, with IGF-I and bFGF being particularly significant.
  • The expression of bFGF receptors on melanoma cells presents a potential therapeutic target for melanoma treatment.

Related Concept Videos